198 related articles for article (PubMed ID: 21533058)
1. The cytoplasmic domain of MUC1 induces hyperplasia in the mammary gland and correlates with nuclear accumulation of β-catenin.
Li Y; Yi H; Yao Y; Liao X; Xie Y; Yang J; Yan Z; Wang L; Lu S; Kuang Y; Gu M; Fei J; Wang Z; Huang L
PLoS One; 2011 Apr; 6(4):e19102. PubMed ID: 21533058
[TBL] [Abstract][Full Text] [Related]
2. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.
Schroeder JA; Adriance MC; Thompson MC; Camenisch TD; Gendler SJ
Oncogene; 2003 Mar; 22(9):1324-32. PubMed ID: 12618757
[TBL] [Abstract][Full Text] [Related]
3. MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation.
Schroeder JA; Masri AA; Adriance MC; Tessier JC; Kotlarczyk KL; Thompson MC; Gendler SJ
Oncogene; 2004 Jul; 23(34):5739-47. PubMed ID: 15221004
[TBL] [Abstract][Full Text] [Related]
4. Intracellular MUC1 peptides inhibit cancer progression.
Bitler BG; Menzl I; Huerta CL; Sands B; Knowlton W; Chang A; Schroeder JA
Clin Cancer Res; 2009 Jan; 15(1):100-9. PubMed ID: 19118037
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J; Li Y; Liu Q; Lu W; Bu G
Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
[TBL] [Abstract][Full Text] [Related]
6. MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation.
Huang L; Ren J; Chen D; Li Y; Kharbanda S; Kufe D
Cancer Biol Ther; 2003; 2(6):702-6. PubMed ID: 14688481
[TBL] [Abstract][Full Text] [Related]
7. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.
Teulière J; Faraldo MM; Deugnier MA; Shtutman M; Ben-Ze'ev A; Thiery JP; Glukhova MA
Development; 2005 Jan; 132(2):267-77. PubMed ID: 15590737
[TBL] [Abstract][Full Text] [Related]
8. MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.
Rajabi H; Ahmad R; Jin C; Kosugi M; Alam M; Joshi MD; Kufe D
J Biol Chem; 2012 Mar; 287(13):10703-10713. PubMed ID: 22318732
[TBL] [Abstract][Full Text] [Related]
9. Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia.
Li X; Gonzalez ME; Toy K; Filzen T; Merajver SD; Kleer CG
Am J Pathol; 2009 Sep; 175(3):1246-54. PubMed ID: 19661437
[TBL] [Abstract][Full Text] [Related]
10. PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.
Cortez V; Samayoa C; Zamora A; Martinez L; Tekmal RR; Vadlamudi RK
Cancer Res; 2014 Dec; 74(24):7395-405. PubMed ID: 25377474
[TBL] [Abstract][Full Text] [Related]
11. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
[TBL] [Abstract][Full Text] [Related]
12. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.
Schroeder JA; Thompson MC; Gardner MM; Gendler SJ
J Biol Chem; 2001 Apr; 276(16):13057-64. PubMed ID: 11278868
[TBL] [Abstract][Full Text] [Related]
13. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.
Wagh PK; Zinser GM; Gray JK; Shrestha A; Waltz SE
Endocrinology; 2012 Jun; 153(6):2735-46. PubMed ID: 22474186
[TBL] [Abstract][Full Text] [Related]
14. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.
Al Masri A; Gendler SJ
Oncogene; 2005 Sep; 24(38):5799-808. PubMed ID: 15897873
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
16. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
17. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS
J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661
[TBL] [Abstract][Full Text] [Related]
18. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.
Huang L; Chen D; Liu D; Yin L; Kharbanda S; Kufe D
Cancer Res; 2005 Nov; 65(22):10413-22. PubMed ID: 16288032
[TBL] [Abstract][Full Text] [Related]
19. Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.
Li Y; Yu WH; Ren J; Chen W; Huang L; Kharbanda S; Loda M; Kufe D
Mol Cancer Res; 2003 Aug; 1(10):765-75. PubMed ID: 12939402
[TBL] [Abstract][Full Text] [Related]
20. Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.
Khodarev N; Ahmad R; Rajabi H; Pitroda S; Kufe T; McClary C; Joshi MD; MacDermed D; Weichselbaum R; Kufe D
Oncogene; 2010 Feb; 29(6):920-9. PubMed ID: 19915608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
